APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ketorolac Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ketorolac Injection Industry Growth and Trends Forecast to 2032

Report ID 174005650122 December 2025103 pages

Choose your research edition.

Industry ResearchKetorolac Injection Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Ketorolac Injection Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Ketorolac Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ketorolac Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Ketorolac Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Ketorolac Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ketorolac Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ketorolac Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ketorolac Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ketorolac Injection include Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), Sagent Pharmaceuticals, Hikma, Lunan Pharma, Alvogen, Chengdu Brilliant Pharmaceuticals and Athenex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ketorolac Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ketorolac Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ketorolac Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ketorolac Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ketorolac Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ketorolac Injection Market by Company

Pfizer

Fresenius Kabi

Fosun Pharma (Gland Pharma)

Sagent Pharmaceuticals

Hikma

Lunan Pharma

Alvogen

Chengdu Brilliant Pharmaceuticals

Athenex

Sichuan Medcalo

Julphar Bangladesh Ltd.

Yung Shin Pharm

Tianjin Chase Sun Pharmaceutical

ZISKA Pharmaceuticals

Ketorolac Injection Segment by Concentration

15mg/ml

30mg/ml

Ketorolac Injection Segment by Application

Hospital

Clinics

Others

Ketorolac Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ketorolac Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ketorolac Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ketorolac Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ketorolac Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ketorolac Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 15mg/ml Table 2. Major Company of 30mg/ml Table 3. Global Ketorolac Injection Sales by Concentration (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Ketorolac Injection Sales by Concentration (2021-2026) & (K Units) Table 5. Global Ketorolac Injection Sales Market Share in Volume by Concentration (2021-2026) Table 6. Global Ketorolac Injection Sales by Concentration (2021-2026) & (US$ Million) Table 7. Global Ketorolac Injection Sales Market Share in Value by Concentration (2021-2026) Table 8. Global Ketorolac Injection Price by Concentration (2021-2026) & (US$/K Units) Table 9. Global Ketorolac Injection Sales by Concentration (2027-2032) & (K Units) Table 10. Global Ketorolac Injection Sales Market Share in Volume by Concentration (2027-2032) Table 11. Global Ketorolac Injection Sales by Concentration (2027-2032) & (US$ Million) Table 12. Global Ketorolac Injection Sales Market Share in Value by Concentration (2027-2032) Table 13. Global Ketorolac Injection Price by Concentration (2027-2032) & (US$/K Units) Table 14. North America Ketorolac Injection Sales by Concentration (2021-2026) & (K Units) Table 15. North America Ketorolac Injection Sales by Concentration (2021-2026) & (US$ Million) Table 16. Europe Ketorolac Injection Sales by Concentration (2021-2026) & (K Units) Table 17. Europe Ketorolac Injection Sales by Concentration (2021-2026) & (US$ Million) Table 18. Asia-Pacific Ketorolac Injection Sales by Concentration (2021-2026) & (K Units) Table 19. Asia-Pacific Ketorolac Injection Sales by Concentration (2021-2026) & (US$ Million) Table 20. Latin America Ketorolac Injection Sales by Concentration (2021-2026) & (K Units) Table 21. Latin America Ketorolac Injection Sales by Concentration (2021-2026) & (US$ Million) Table 22. Middle East and Africa Ketorolac Injection Sales by Concentration (2021-2026) & (K Units) Table 23. Middle East and Africa Ketorolac Injection Sales by Concentration (2021-2026) & (US$ Million) Table 24. Ketorolac Injection Industry Trends Table 25. Ketorolac Injection Industry Drivers Table 26. Ketorolac Injection Industry Opportunities and Challenges Table 27. Ketorolac Injection Industry Restraints Table 28. Global Ketorolac Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Ketorolac Injection Revenue Market Share by Company (2021-2026) Table 30. Global Ketorolac Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Ketorolac Injection Sales Share by Company (2021-2026) Table 32. Global Ketorolac Injection Market Price by Company (2021-2026) & (US$/K Units) Table 33. Global Ketorolac Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Ketorolac Injection Major Company Production Sites and Headquarters Table 35. Global Ketorolac Injection Company, Product Type & Application Table 36. Global Ketorolac Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Ketorolac Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Ketorolac Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Ketorolac Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Ketorolac Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Ketorolac Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Ketorolac Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Ketorolac Injection Sales (K Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 45. Global Ketorolac Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Ketorolac Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Ketorolac Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Ketorolac Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Ketorolac Injection Sales (K Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2027-2032) Table 50. Global Ketorolac Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Ketorolac Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Ketorolac Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Ketorolac Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Ketorolac Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Ketorolac Injection Price by Application (2021-2026) & (US$/K Units) Table 56. Global Ketorolac Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Ketorolac Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Ketorolac Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Ketorolac Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Ketorolac Injection Price by Application (2027-2032) & (US$/K Units) Table 61. North America Ketorolac Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Ketorolac Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Ketorolac Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Ketorolac Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Ketorolac Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Ketorolac Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Ketorolac Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Ketorolac Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Ketorolac Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Ketorolac Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 74. Pfizer Ketorolac Injection Product Portfolio Table 75. Pfizer Recent Development Table 76. Fresenius Kabi Company Information Table 77. Fresenius Kabi Business Overview Table 78. Fresenius Kabi Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 79. Fresenius Kabi Ketorolac Injection Product Portfolio Table 80. Fresenius Kabi Recent Development Table 81. Fosun Pharma (Gland Pharma) Company Information Table 82. Fosun Pharma (Gland Pharma) Business Overview Table 83. Fosun Pharma (Gland Pharma) Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 84. Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio Table 85. Fosun Pharma (Gland Pharma) Recent Development Table 86. Sagent Pharmaceuticals Company Information Table 87. Sagent Pharmaceuticals Business Overview Table 88. Sagent Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 89. Sagent Pharmaceuticals Ketorolac Injection Product Portfolio Table 90. Sagent Pharmaceuticals Recent Development Table 91. Hikma Company Information Table 92. Hikma Business Overview Table 93. Hikma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 94. Hikma Ketorolac Injection Product Portfolio Table 95. Hikma Recent Development Table 96. Lunan Pharma Company Information Table 97. Lunan Pharma Business Overview Table 98. Lunan Pharma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 99. Lunan Pharma Ketorolac Injection Product Portfolio Table 100. Lunan Pharma Recent Development Table 101. Alvogen Company Information Table 102. Alvogen Business Overview Table 103. Alvogen Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 104. Alvogen Ketorolac Injection Product Portfolio Table 105. Alvogen Recent Development Table 106. Chengdu Brilliant Pharmaceuticals Company Information Table 107. Chengdu Brilliant Pharmaceuticals Business Overview Table 108. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 109. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio Table 110. Chengdu Brilliant Pharmaceuticals Recent Development Table 111. Athenex Company Information Table 112. Athenex Business Overview Table 113. Athenex Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 114. Athenex Ketorolac Injection Product Portfolio Table 115. Athenex Recent Development Table 116. Sichuan Medcalo Company Information Table 117. Sichuan Medcalo Business Overview Table 118. Sichuan Medcalo Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 119. Sichuan Medcalo Ketorolac Injection Product Portfolio Table 120. Sichuan Medcalo Recent Development Table 121. Julphar Bangladesh Ltd. Company Information Table 122. Julphar Bangladesh Ltd. Business Overview Table 123. Julphar Bangladesh Ltd. Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 124. Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio Table 125. Julphar Bangladesh Ltd. Recent Development Table 126. Yung Shin Pharm Company Information Table 127. Yung Shin Pharm Business Overview Table 128. Yung Shin Pharm Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 129. Yung Shin Pharm Ketorolac Injection Product Portfolio Table 130. Yung Shin Pharm Recent Development Table 131. Tianjin Chase Sun Pharmaceutical Company Information Table 132. Tianjin Chase Sun Pharmaceutical Business Overview Table 133. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 134. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio Table 135. Tianjin Chase Sun Pharmaceutical Recent Development Table 136. ZISKA Pharmaceuticals Company Information Table 137. ZISKA Pharmaceuticals Business Overview Table 138. ZISKA Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 139. ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio Table 140. ZISKA Pharmaceuticals Recent Development Table 141. North America Ketorolac Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. North America Ketorolac Injection Sales by Country (2021-2026) & (K Units) Table 143. North America Ketorolac Injection Sales Market Share by Country (2021-2026) Table 144. North America Ketorolac Injection Sales Forecast by Country (2027-2032) & (K Units) Table 145. North America Ketorolac Injection Sales Market Share Forecast by Country (2027-2032) Table 146. North America Ketorolac Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Ketorolac Injection Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Ketorolac Injection Market Share by Country (2021-2026) Table 149. North America Ketorolac Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Ketorolac Injection Market Share Forecast by Country (2027-2032) Table 151. Europe Ketorolac Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Europe Ketorolac Injection Sales by Country (2021-2026) & (K Units) Table 153. Europe Ketorolac Injection Sales Market Share by Country (2021-2026) Table 154. Europe Ketorolac Injection Sales Forecast by Country (2027-2032) & (K Units) Table 155. Europe Ketorolac Injection Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Ketorolac Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Ketorolac Injection Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Ketorolac Injection Market Share by Country (2021-2026) Table 159. Europe Ketorolac Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Ketorolac Injection Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Ketorolac Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Ketorolac Injection Sales by Country (2021-2026) & (K Units) Table 163. Asia-Pacific Ketorolac Injection Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Ketorolac Injection Sales Forecast by Country (2027-2032) & (K Units) Table 165. Asia-Pacific Ketorolac Injection Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Ketorolac Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Ketorolac Injection Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Ketorolac Injection Market Share by Country (2021-2026) Table 169. Asia-Pacific Ketorolac Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Ketorolac Injection Market Share Forecast by Country (2027-2032) Table 171. Latin America Ketorolac Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Latin America Ketorolac Injection Sales by Country (2021-2026) & (K Units) Table 173. Latin America Ketorolac Injection Sales Market Share by Country (2021-2026) Table 174. Latin America Ketorolac Injection Sales Forecast by Country (2027-2032) & (K Units) Table 175. Latin America Ketorolac Injection Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Ketorolac Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Ketorolac Injection Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Ketorolac Injection Market Share by Country (2021-2026) Table 179. Latin America Ketorolac Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Ketorolac Injection Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Ketorolac Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Ketorolac Injection Sales by Country (2021-2026) & (K Units) Table 183. Middle East and Africa Ketorolac Injection Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Ketorolac Injection Sales Forecast by Country (2027-2032) & (K Units) Table 185. Middle East and Africa Ketorolac Injection Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Ketorolac Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Ketorolac Injection Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Ketorolac Injection Market Share by Country (2021-2026) Table 189. Middle East and Africa Ketorolac Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Ketorolac Injection Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Ketorolac Injection Distributors List Table 194. Ketorolac Injection Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Ketorolac Injection Image Figure 2. Global Ketorolac Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ketorolac Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Ketorolac Injection Sales (2021-2032) & (K Units) Figure 5. 15mg/ml Image Figure 6. Global 15mg/ml Sales YoY Growth (2021-2032) & (K Units) Figure 7. 30mg/ml Image Figure 8. Global 30mg/ml Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Ketorolac Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Ketorolac Injection Market Share by Type 2025 VS 2032 Figure 11. North America Ketorolac Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Ketorolac Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Ketorolac Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Ketorolac Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Ketorolac Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Ketorolac Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Ketorolac Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Ketorolac Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Ketorolac Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Ketorolac Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Ketorolac Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinics Image Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Ketorolac Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Ketorolac Injection Market Share by Application 2025 VS 2032 Figure 31. North America Ketorolac Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Ketorolac Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Ketorolac Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Ketorolac Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Ketorolac Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Ketorolac Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Ketorolac Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Ketorolac Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Ketorolac Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Ketorolac Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Ketorolac Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Ketorolac Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Ketorolac Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Ketorolac Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Ketorolac Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Ketorolac Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Ketorolac Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Ketorolac Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Ketorolac Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Ketorolac Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Ketorolac Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Ketorolac Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Ketorolac Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Ketorolac Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Ketorolac Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Ketorolac Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Ketorolac Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Ketorolac Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Ketorolac Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Ketorolac Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Ketorolac Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Ketorolac Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 15mg/ml
  • 30mg/ml
Applications
  • Hospital
  • Clinics
  • Others
Companies covered
  • Pfizer
  • Fresenius Kabi
  • Fosun Pharma (Gland Pharma)
  • Sagent Pharmaceuticals
  • Hikma
  • Lunan Pharma
  • Alvogen
  • Chengdu Brilliant Pharmaceuticals
  • Athenex
  • Sichuan Medcalo
  • Julphar Bangladesh Ltd.
  • Yung Shin Pharm
  • Tianjin Chase Sun Pharmaceutical
  • ZISKA Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ketorolac Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ketorolac Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ketorolac Injection Market by Concentration
  6. 1.3.1 15mg/ml
  7. 1.3.2 30mg/ml
  8. 1.4 Global Ketorolac Injection Market Size by Concentration
  9. 1.4.1 Global Ketorolac Injection Market Size Overview by Concentration (2021-2032)
  10. 1.4.2 Global Ketorolac Injection Historic Market Size Review by Concentration (2021-2026)
  11. 1.4.3 Global Ketorolac Injection Forecasted Market Size by Concentration (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Ketorolac Injection Sales Breakdown by Concentration (2021-2026)
  14. 1.5.2 Europe Ketorolac Injection Sales Breakdown by Concentration (2021-2026)
  15. 1.5.3 Asia-Pacific Ketorolac Injection Sales Breakdown by Concentration (2021-2026)
  16. 1.5.4 South America Ketorolac Injection Sales Breakdown by Concentration (2021-2026)
  17. 1.5.5 Middle East and Africa Ketorolac Injection Sales Breakdown by Concentration (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ketorolac Injection Industry Trends
  2. 2.2 Ketorolac Injection Industry Drivers
  3. 2.3 Ketorolac Injection Industry Opportunities and Challenges
  4. 2.4 Ketorolac Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ketorolac Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Ketorolac Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Ketorolac Injection Price (2021-2026)
  4. 3.4 Global Ketorolac Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ketorolac Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Ketorolac Injection Company, Product Type & Application
  7. 3.7 Global Ketorolac Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ketorolac Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ketorolac Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ketorolac Injection Tier 1, Tier 2, and Tier 3
4 Ketorolac Injection Regional Status and Outlook
  1. 4.1 Global Ketorolac Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ketorolac Injection Historic Market Size by Region
  3. 4.2.1 Global Ketorolac Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ketorolac Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ketorolac Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ketorolac Injection Forecasted Market Size by Region
  7. 4.3.1 Global Ketorolac Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ketorolac Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ketorolac Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ketorolac Injection by Application
  1. 5.1 Ketorolac Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Ketorolac Injection Market Size by Application
  6. 5.2.1 Global Ketorolac Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Ketorolac Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Ketorolac Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Ketorolac Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Ketorolac Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Ketorolac Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Ketorolac Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Ketorolac Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Ketorolac Injection Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 Fresenius Kabi
  8. 6.2.1 Fresenius Kabi Company Information
  9. 6.2.2 Fresenius Kabi Business Overview
  10. 6.2.3 Fresenius Kabi Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Fresenius Kabi Ketorolac Injection Product Portfolio
  12. 6.2.5 Fresenius Kabi Recent Developments
  13. 6.3 Fosun Pharma (Gland Pharma)
  14. 6.3.1 Fosun Pharma (Gland Pharma) Company Information
  15. 6.3.2 Fosun Pharma (Gland Pharma) Business Overview
  16. 6.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio
  18. 6.3.5 Fosun Pharma (Gland Pharma) Recent Developments
  19. 6.4 Sagent Pharmaceuticals
  20. 6.4.1 Sagent Pharmaceuticals Company Information
  21. 6.4.2 Sagent Pharmaceuticals Business Overview
  22. 6.4.3 Sagent Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sagent Pharmaceuticals Ketorolac Injection Product Portfolio
  24. 6.4.5 Sagent Pharmaceuticals Recent Developments
  25. 6.5 Hikma
  26. 6.5.1 Hikma Company Information
  27. 6.5.2 Hikma Business Overview
  28. 6.5.3 Hikma Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hikma Ketorolac Injection Product Portfolio
  30. 6.5.5 Hikma Recent Developments
  31. 6.6 Lunan Pharma
  32. 6.6.1 Lunan Pharma Company Information
  33. 6.6.2 Lunan Pharma Business Overview
  34. 6.6.3 Lunan Pharma Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lunan Pharma Ketorolac Injection Product Portfolio
  36. 6.6.5 Lunan Pharma Recent Developments
  37. 6.7 Alvogen
  38. 6.7.1 Alvogen Company Information
  39. 6.7.2 Alvogen Business Overview
  40. 6.7.3 Alvogen Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Alvogen Ketorolac Injection Product Portfolio
  42. 6.7.5 Alvogen Recent Developments
  43. 6.8 Chengdu Brilliant Pharmaceuticals
  44. 6.8.1 Chengdu Brilliant Pharmaceuticals Company Information
  45. 6.8.2 Chengdu Brilliant Pharmaceuticals Business Overview
  46. 6.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio
  48. 6.8.5 Chengdu Brilliant Pharmaceuticals Recent Developments
  49. 6.9 Athenex
  50. 6.9.1 Athenex Company Information
  51. 6.9.2 Athenex Business Overview
  52. 6.9.3 Athenex Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Athenex Ketorolac Injection Product Portfolio
  54. 6.9.5 Athenex Recent Developments
  55. 6.10 Sichuan Medcalo
  56. 6.10.1 Sichuan Medcalo Company Information
  57. 6.10.2 Sichuan Medcalo Business Overview
  58. 6.10.3 Sichuan Medcalo Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sichuan Medcalo Ketorolac Injection Product Portfolio
  60. 6.10.5 Sichuan Medcalo Recent Developments
  61. 6.11 Julphar Bangladesh Ltd.
  62. 6.11.1 Julphar Bangladesh Ltd. Company Information
  63. 6.11.2 Julphar Bangladesh Ltd. Business Overview
  64. 6.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio
  66. 6.11.5 Julphar Bangladesh Ltd. Recent Developments
  67. 6.12 Yung Shin Pharm
  68. 6.12.1 Yung Shin Pharm Company Information
  69. 6.12.2 Yung Shin Pharm Business Overview
  70. 6.12.3 Yung Shin Pharm Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Yung Shin Pharm Ketorolac Injection Product Portfolio
  72. 6.12.5 Yung Shin Pharm Recent Developments
  73. 6.13 Tianjin Chase Sun Pharmaceutical
  74. 6.13.1 Tianjin Chase Sun Pharmaceutical Company Information
  75. 6.13.2 Tianjin Chase Sun Pharmaceutical Business Overview
  76. 6.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio
  78. 6.13.5 Tianjin Chase Sun Pharmaceutical Recent Developments
  79. 6.14 ZISKA Pharmaceuticals
  80. 6.14.1 ZISKA Pharmaceuticals Company Information
  81. 6.14.2 ZISKA Pharmaceuticals Business Overview
  82. 6.14.3 ZISKA Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio
  84. 6.14.5 ZISKA Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Ketorolac Injection Sales by Country
  2. 7.1.1 North America Ketorolac Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ketorolac Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Ketorolac Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ketorolac Injection Market Size by Country
  6. 7.2.1 North America Ketorolac Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ketorolac Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Ketorolac Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ketorolac Injection Sales by Country
  2. 8.1.1 Europe Ketorolac Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ketorolac Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Ketorolac Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ketorolac Injection Market Size by Country
  6. 8.2.1 Europe Ketorolac Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ketorolac Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ketorolac Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ketorolac Injection Sales by Country
  2. 9.1.1 Asia-Pacific Ketorolac Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ketorolac Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ketorolac Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ketorolac Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Ketorolac Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ketorolac Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ketorolac Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ketorolac Injection Sales by Country
  2. 10.1.1 South America Ketorolac Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ketorolac Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Ketorolac Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ketorolac Injection Market Size by Country
  6. 10.2.1 South America Ketorolac Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ketorolac Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Ketorolac Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ketorolac Injection Sales by Country
  2. 11.1.1 Middle East and Africa Ketorolac Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ketorolac Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ketorolac Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ketorolac Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Ketorolac Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ketorolac Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ketorolac Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ketorolac Injection Value Chain Analysis
  2. 12.1.1 Ketorolac Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ketorolac Injection Production Mode & Process
  7. 12.2 Ketorolac Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ketorolac Injection Distributors
  10. 12.2.3 Ketorolac Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst